CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS
International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®
PureIMS gears up for abbreviated registration of Levodopa Cyclops® against OFF episodes in Parkinson’s disease with the successful completion of a comparative pharmacokinetic study
PureIMS secures new investment round to develop lead inhalation product and facilitate partnering activities